Louisbourg Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.41M Sell
21,016
-11,896
-36% -$2.77M 0.83% 52
2025
Q4
$5.67M Sell
32,912
-6,660
-17% -$1.32M 1.13% 31
2025
Q3
$5.91M Sell
39,572
-2,540
-6% -$435K 1.29% 27
2025
Q2
$5.2M Buy
42,112
+1,795
+4% +$276K 1.23% 28
2025
Q1
$5.27M Sell
40,317
-7,385
-15% -$1.16M 1.43% 20
2024
Q4
$5.37M Buy
47,702
+3,055
+7% +$473K 1.41% 20
2024
Q3
$5.9M Sell
44,647
-60
-0.1% -$9.56K 1.49% 18
2024
Q2
$5.28M Buy
44,707
+3,100
+7% +$461K 1.48% 20
2024
Q1
$5.38M Buy
41,607
+5,106
+14% +$813K 1.49% 27
2023
Q4
$4.8M Buy
+36,501
New +$5.6M 1.45% 19

Other funds holding JNJ

Louisbourg Investments's JNJ Position: Q1 2026 in Review

Louisbourg Investments reduced its Johnson & Johnson (JNJ) stake by 36% in Q1 2026, selling an estimated $2.77M and leaving 21,016 shares worth $4.41M. The position accounts for 0.83% of the portfolio, ranked #52.

Louisbourg Investments first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.91M in Q3 2025. 4,612 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Louisbourg Investments held 21,016 shares of Johnson & Johnson worth $4.41M as of Q1 2026.
  • Louisbourg Investments sold 11,896 Johnson & Johnson shares in Q1 2026, an estimated $2.77M.
  • Johnson & Johnson made up 0.83% of Louisbourg Investments's portfolio in Q1 2026, its #52 holding.
  • Louisbourg Investments first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • Louisbourg Investments's Johnson & Johnson position peaked at $5.91M in Q3 2025.
  • 4,612 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Louisbourg Investments's 13F filing for Q1 2026, filed 22 Apr 2026.